SMTL ID : 6fyk.2 (2 other biounits)

X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.39 Å

Oligo State

monomer

Ligands

1 x EAZ: (2~{S})-4-methyl-1-[5-(3-methyl-2~{H}-indazol-5-yl)pyridin-3-yl]oxy-pentan-2-amine(Non-covalent)

EAZ.1: 16 residues within 4Å: Chain A: L.36, E.38, F.41, V.44, A.58, K.60, V.94, F.110, E.111, L.112, L.113, E.161, N.162, L.164, V.193, D.194 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.36, A:V.44, A:V.94, A:F.110, A:F.110, A:L.164, A:V.193, A:V.193, A:V.193 Hydrogen bonds: A:L.113, A:L.113, A:N.162, A:D.194 Water bridges: A:E.75, A:K.159, A:N.162

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kallen, J. et al., X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome. ChemMedChem (2018)

Release Date

2018-07-18

Peptides

Dual specificity protein kinase CLK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Dual specificity protein kinase CLK2

Related Entries With Identical Sequence